The results demonstrated a significant decrease in Ki67 levels in tumors treated with flavokawain C compared to PBS treatment (Fig. 9F), indicating that flavokawain C strongly inhibited tumor growth in mice. This evidence concerns the gene MKI67 and neoplasm.